Radionuclide Drug Conjugates Market – Advancing Targeted Radiopharmaceuticals
The Radionuclide Drug Conjugates (RDC) Market relates to therapeutic approaches that combine radioactive isotopes with targeting molecules designed to deliver radiation to selected biological targets. These technologies are being investigated particularly in oncology, where targeted radiation may help treat specific tumors.
Current Market Landscape
The field includes radiopharmaceutical...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek